Volume 21, Number 5—May 2015
Research
Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012
Table 2
Cluster | Transmission, participant ID no. | Period of co-location | Prison ID† | Patient ID | Est. date of infection | HCV genotype | ATSI | Continuously in prison‡ | Equipment sharing§ | OST§ | Heroin use§ |
---|---|---|---|---|---|---|---|---|---|---|---|
A | 315 → 117 | 2007 Dec 31–2008 Jan 22 | AT | 315 | 2007 Oct 30 | 1a | No | Yes | Yes | No | No |
117 | 2008 Feb 27 | 1a | No | No | Yes | No | Yes | ||||
315 → 461 | 2008 Jun 29–Jul 11 | AE | 315 | 2007 Oct 30 | 1a | No | Yes | Yes | No | No | |
2008 Sep 24–Oct 1 | 461 | 2008 Oct 6 | 1a | No | No | Yes | No | Yes | |||
B | 304 → 357 | 2007 Oct 26–Nov 23 | AB | 304 | 2007 Apr 17 | 3a | No | No | No | No | No |
357 | 2008 Nov 11 | 3a | No | Yes | Yes | No | Yes | ||||
C | 302 → 426 | 2008 Dec 9–18 | AP | 302§ | 2007 Oct 11 | 3a | Yes | No | Yes | No | No |
426 | 2008 Dec 21 | 3a | Yes | No | Yes | Yes | No |
*All prisoners were injection drug users during the period of co-location. ATSI, Aboriginal and/or Torres Strait Islander descent; est., estimated; HCV, hepatitis C virus; ID, identification; OST, opioid substitution therapy.
†Prisons are identified by codes for de-identification purposes.
‡Continuously in prison 6 mo before estimated date of infection.
§Female patient. All others were male.
1Additional HITS-p investigators are listed at the end of this article.
Page created: April 20, 2015
Page updated: April 20, 2015
Page reviewed: April 20, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.